Home › Research › Brain scans and imaging
Imaging of Tau Pathology in Neurodegenerative Diseases: An Update
Beyer L, Brendel M.. Seminars in nuclear medicine, 2020-12-20
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Pathological accumulated misfolded tau underlies various neurodegenerative diseases and associated clinical syndromes. To diagnose those diseases reliable before death or even at early stages, many different tau-specific radiotracers have been developed in the last decade to be used with positron-emission-tomography. In contrast to amyloid-β imaging, different isoforms of tau exist further complicating radiotracer development. First-generation radiotracers like [ 11 C]PBB3, [ 18 F]AV1451 and [ 18 F]THK5351 have been extensively investigated in vitro and in vivo. In Alzheimer's disease (AD), high specific binding could be detected, and evidence of clinical applicability recently led to clinical approval of [ 18 F]flortaucipir ([ 18 F]AV1451) by the FDA. Nevertheless, absent or minor binding to non-AD tau isoforms and high off-target binding to non-tau brain structures limit the diagnostic applicability especially in non-AD tauopathies demanding further tracer development. In vitro assays and autoradiography results of next-generation radiotracers [ 18 F]MK-6240, [ 18 F]RO-948, [ 18 F]PM-PBB3, [ 18 F]GTP-1 and [ 18 F]PI-2620 clearly indicate less off-target binding and high specific binding to tau neurofibrils. First in human studies have been conducted with promising results for all tracers in AD patients, and also some positive experience in non-AD tauopathies. Overall, larger scaled autoradiography and human studies are needed to further evaluate the most promising candidates and support future clinical approval.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Beyer, L., & Brendel, M. (2021). Imaging of Tau Pathology in Neurodegenerative Diseases: An Update. Seminars in nuclear medicine. https://doi.org/10.1053/j.semnuclmed.2020.12.004
Vancouver
Beyer L, Brendel M. Imaging of Tau Pathology in Neurodegenerative Diseases: An Update. Seminars in nuclear medicine. 2021. doi:10.1053/j.semnuclmed.2020.12.004. PMID: 33353724.
BibTeX
@article{beyer2021-33353724,
author = {Beyer, L. and Brendel, M.},
title = {{Imaging of Tau Pathology in Neurodegenerative Diseases: An Update}},
journal = {Seminars in nuclear medicine},
year = {2021},
doi = {10.1053/j.semnuclmed.2020.12.004},
pmid = {33353724},
url = {https://doi.org/10.1053/j.semnuclmed.2020.12.004}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- In vitro assays and autoradiography results of next-generation radiotracers [ 18 F]MK-6240, [ 18 F]RO-948, [ 18 F]PM-PBB3, [ 18 F]GTP-1 and [ 18 F]PI-2620 clearly indicate less off-target binding and high specific binding to tau neurofibrils.
- First in human studies have been conducted with promising results for all tracers in AD patients, and also some positive experience in non-AD tauopathies.
- Overall, larger scaled autoradiography and human studies are needed to further evaluate the most promising candidates and support future clinical approval.
New to this subject? Start with our plain-English guide: Brain scans & tests →
Study details
- Evidence strengthLow
How this study scored 40/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 23 of the 58 points we could judge it on, which is 40 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Seminars in nuclear medicine) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2021 — within 6 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 33353724) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 23 / 58 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 23 of the 58 points we could judge it on is 40 out of 100. |
| Total | 40 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Brain scans and imaging from nearby years
Also tagged “tau-pathology”
10 studies in the library carry the topic tag “tau-pathology”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 10 tagged studies.